Species differences in bradykinin receptor-mediated responses of the airways.
1. Bradykinin (BK) is a nine amino acid peptide (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) formed from the plasma precursor kininogen during inflammation and tissue injury. The actions of BK are mediated by G protein-coupled cell surface receptors, designated B1 and B2. 2. BK has a plethora of effects in the airways including bronchoconstriction, bronchodilation, stimulation of cholinergic and sensory nerves, mucus secretion, cough and oedema resulting from promotion of microvascular leakage. These airway effects are mediated in the main by the B2 receptor subtype. 3. BK acts mainly indirectly, primarily through airway nerve activation, but also by the release of prostanoids, thromboxanes and nitric oxide (NO). 4. Airway responses to BK have been studied in detail in guinea-pigs, mice, sheep and rats. This review describes the effects of BK in these species and draws comparison with its effects in normal humans and patients with respiratory diseases. 5. Despite its many and varied effects in the airways of animals and man, the exact contribution of BK to airways disease remains unclear.
Ellis
K M
KM
Research Department, Novartis Pharma AG, CH-4002 Basel, Switzerland.
Fozard
J R
JR
D000818:Animals; D001920:Bradykinin / Q000378:metabolism* / Q000494:pharmacology* / Q000502:physiology; D065168:Bradykinin Receptor Antagonists; D016084:Bronchoconstriction / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000502:physiology*; D018002:Receptors, Bradykinin / Q000819:agonists / Q000502:physiology*; D012137:Respiratory System / Q000187:drug effects; D013045:Species Specificity
D065168:Bradykinin Receptor Antagonists; D018002:Receptors, Bradykinin; D001920:Bradykinin